BPC-157's Gut Protection Involves Both Adrenaline and Dopamine Signaling Systems

BPC-157's gastroprotective effects interact with both adrenergic and dopaminergic signaling systems, revealing a complex multi-system mechanism of action.

Sikirić, P et al.·Digestive diseases and sciences·1997·Preliminary EvidenceAnimal StudyAnimal Study
RPEP-00430Animal StudyPreliminary Evidence1997RETHINKTHC RESEARCH DATABASErethinkthc.com/research

Quick Facts

Study Type
Animal Study
Evidence
Preliminary Evidence
Sample
Not reported

What This Study Found

BPC-157's mucosal protection in stress involves interactions with both adrenergic and dopaminergic neurotransmitter systems.

Key Numbers

How They Did This

Animal study testing BPC-157's gastroprotective effects in stress-induced lesion models with pharmacological manipulation of adrenergic and dopaminergic pathways.

Why This Research Matters

Understanding that BPC-157 works through neurotransmitter systems explains how it protects multiple organ systems — it modulates the central stress response, not just local tissue.

The Bigger Picture

BPC-157's interaction with neurotransmitter systems connects its gut-protective effects to its broader neuroprotective and anti-stress properties.

What This Study Doesn't Tell Us

Animal study with pharmacological manipulation. Specific agonists/antagonists used and quantitative results not detailed in abstract.

Questions This Raises

  • ?Does BPC-157 modulate central stress responses that then protect peripheral organs?
  • ?Which specific adrenergic and dopaminergic receptor subtypes mediate BPC-157's effects?

Trust & Context

Key Stat:
Dual neurotransmitter interaction BPC-157's gastroprotection involves both adrenergic and dopaminergic system modulation
Evidence Grade:
Moderate animal evidence with pharmacological pathway analysis of BPC-157's mechanism.
Study Age:
Published in 1997, revealing neurotransmitter involvement in BPC-157's protective mechanism.
Original Title:
Pentadecapeptide BPC 157 interactions with adrenergic and dopaminergic systems in mucosal protection in stress.
Published In:
Digestive diseases and sciences, 42(3), 661-71 (1997)
Database ID:
RPEP-00430

Evidence Hierarchy

Meta-Analysis / Systematic Review
Randomized Controlled Trial
Cohort / Case-Control
Cross-Sectional / Observational
Case Report / Animal StudyOne case or non-human subjects
This study

Tests effects in animals (usually mice or rats), not humans.

What do these levels mean? →

Frequently Asked Questions

Why do neurotransmitters matter for gut protection?

The gut has its own nervous system (enteric nervous system) that uses the same neurotransmitters as the brain — including adrenaline and dopamine. BPC-157's interaction with these systems suggests it protects the gut by modulating nervous system signaling.

Does this explain BPC-157's effects on mood?

Possibly. If BPC-157 interacts with dopamine signaling, it could affect mood and motivation alongside its gut-protective effects. This neurotransmitter connection may explain user reports of improved well-being.

Read More on RethinkPeptides

Cite This Study

RPEP-00430·https://rethinkpeptides.com/research/RPEP-00430

APA

Sikirić, P; Mazul, B; Seiwerth, S; Grabarević, Z; Rucman, R; Petek, M; Jagić, V; Turković, B; Rotkvić, I; Mise, S; Zoricić, I; Jurina, L; Konjevoda, P; Hanzevacki, M; Gjurasin, M; Separović, J; Ljubanović, D; Artuković, B; Bratulić, M; Tisljar, M; Miklić, P; Sumajstorcić, J. (1997). Pentadecapeptide BPC 157 interactions with adrenergic and dopaminergic systems in mucosal protection in stress.. Digestive diseases and sciences, 42(3), 661-71.

MLA

Sikirić, P, et al. "Pentadecapeptide BPC 157 interactions with adrenergic and dopaminergic systems in mucosal protection in stress.." Digestive diseases and sciences, 1997.

RethinkPeptides

RethinkPeptides Research Database. "Pentadecapeptide BPC 157 interactions with adrenergic and do..." RPEP-00430. Retrieved from https://rethinkpeptides.com/research/sikiric-1997-pentadecapeptide-bpc-157-interactions

Access the Original Study

Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.

This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.